Risk of neoplasia in renal transplant patients

The Lancet

Volumn 346, Issue 8972, 1995, Pages 403-406

  London, N J ^a   Farmery, S M ^a   Lodge, J P A ^a   Will, E J ^a   Davidson, A M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CONTROLLED STUDY; HUMAN; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; NEOPLASM; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL; UNITED KINGDOM;

EID: 0029128391     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)92780-8     Document Type: Article

References (17)

1. Malignant lymphomas in transplant patients
2. Cancers following cyclosporin therapy
3. Cancer in renal allograft recipients in Australia and New Zealand
4. The changing pattern of posttransplant malignancies
5. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation
6. Premalignant and malignant skin lesions in renal transplant patients
7. Skin cancer in renal transplant recipients
8. Malignant tumours in renal transplant patients
9. De novo malignant tumours during drug immunosuppression: the findings following 1245 cadaveric kidney transplants in 1080 patients
10. Increased risk of malignant tumors in renal transplant recipients receiving cyclosporin
11. Non parametric estimation from incomplete observations
12. De novo tumors in pediatric organ transplant recipients
13. Increased incidence of malignancy during chronic renal failure
14. Combined report on regular dialysis and transplantation in Europe, XIV 1983
15. Cancer incidence in patients on chronic dialysis and in renal transplant recipients